journal article·2018-12-26Open access

Dual Role of Magnetic Nanoparticles as Intracellular Hotspots and Extracellular Matrix Disruptors Triggered by Magnetic Hyperthermia in 3D Cell Culture Models

Lilianne Beola, Laura Asín, Raluca M. Fratila, Vanessa Herrero, Jesús M. de la Fuente, Valeria Grazú, Lucía Gutiérrez

ACS Applied Materials & Interfaces· Volume 10· Issue 51

Abstract

Magnetic hyperthermia is a promising therapy for the localized treatment of cancer based on the exposure of magnetic nanoparticles to an external alternating magnetic field. In order to evaluate some of the mechanisms involved in the cellular damage caused by this treatment, two different 3D cell culture models were prepared using collagen, which is the most abundant protein of the extracellular matrix. The same amount of nanoparticles was added to cells either before or after their incorporation into the 3D structure. Therefore, in one model, particles were located only inside cells (In model), while the other one had particles both inside and outside cells (In&Out model). In the In&Out model, the hyperthermia treatment facilitated the migration of the particles from the outer areas of the 3D structure to the inner parts, achieving a faster homogeneous distribution throughout the whole structure and allowing the particles to gain access to the inner cells. The cell death mechanism activated by the magnetic hyperthermia treatment was different in both models. Necrosis was observed in the In model and apoptosis in the In&Out model 24 h after the hyperthermia application. This was clearly correlated with the amount of nanoparticles located inside the cells. Thus, the combination of both 3D models allowed us to demonstrate two different roles of the magnetic particles during the hyperthermia treatment: (i) The modulation of the cell death mechanism depending on the amount of intracellular particles and (ii) the disruption of the collagen matrix caused by the extracellular nanoparticles.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Ciencia de Materiales de Aragón (ICMA), CSIC/Universidad de Zaragoza, C/Pedro Cerbuna 12, 50009 Zaragoza, Spain

Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 50018 Madrid, Spain

Department of Analytical Chemistry, Instituto Universitario de Nanociencia de Aragón (INA), Universidad de Zaragoza, Edificio I+D, Mariano Esquillor Gómez, 50018 Zaragoza, Spain

Funding

Universidad de Zaragoza · European Commission · Ministerio de Econom?a y Competitividad · European Cooperation in Science and Technology · Fundaci?n Banco Santander · Diputaci?n General de Arag?n

References (66)

Show source-provided references
1. 10.1039/c2cs15337h10.1039/c2cs15337h ↗
2. 10.1039/c0nr00104j10.1039/c0nr00104j ↗
3. 10.1007/978-1-61779-052-2_2110.1007/978-1-61779-052-2_21 ↗
4. 10.1186/1741-7015-8-8310.1186/1741-7015-8-83 ↗
5. 10.1007/s00216-010-4566-y10.1007/s00216-010-4566-y ↗
6. 10.1016/S1748-0132(07)70084-110.1016/S1748-0132(07)70084-1 ↗
7. 10.1016/j.jmmm.2005.01.06410.1016/j.jmmm.2005.01.064 ↗
8. 10.1016/j.nano.2011.08.01710.1016/j.nano.2011.08.017 ↗
9. 10.1021/ja052337c10.1021/ja052337c ↗
10. 10.1016/S0304-8853(99)00088-810.1016/S0304-8853(99)00088-8 ↗
11. 10.1016/j.jconrel.2016.05.06210.1016/j.jconrel.2016.05.062 ↗
12. 10.1016/S1470-2045(02)00818-510.1016/S1470-2045(02)00818-5 ↗
13. 10.1016/j.rpor.2013.09.01110.1016/j.rpor.2013.09.011 ↗
14. 10.1002/biot.20110004510.1002/biot.201100045 ↗
15. 10.1016/j.cis.2011.04.00310.1016/j.cis.2011.04.003 ↗
16. Hildebrandt B. · Crit. Rev. Oncol. Hematol. · 2002 · 43 · 3310.1016/S1040-8428(01)00179-2 ↗
17. 10.1038/srep4278310.1038/srep42783 ↗
18. 10.1038/srep2462910.1038/srep24629 ↗
19. Thorat N. D. · 2016 · 58910.1016/B978-0-323-47347-7.00021-5 ↗
20. 10.1073/pnas.110105310810.1073/pnas.1101053108 ↗
21. 10.1016/j.cell.2010.01.02510.1016/j.cell.2010.01.025 ↗
22. 10.1038/nrm373710.1038/nrm3737 ↗
23. 10.1038/nrc338010.1038/nrc3380 ↗
24. 10.1016/j.biomaterials.2016.11.00810.1016/j.biomaterials.2016.11.008 ↗
25. 10.1016/j.msec.2015.10.06410.1016/j.msec.2015.10.064 ↗
26. 10.1038/s41598-017-09059-710.1038/s41598-017-09059-7 ↗
27. 10.1016/j.drudis.2008.11.00610.1016/j.drudis.2008.11.006 ↗
28. 10.1089/teb.2007.015010.1089/teb.2007.0150 ↗
29. 10.1039/C5SM00084J10.1039/C5SM00084J ↗
30. 10.1073/pnas.091066610610.1073/pnas.0910666106 ↗
31. 10.1126/science.106482910.1126/science.1064829 ↗
32. 10.1038/nmat302510.1038/nmat3025 ↗
33. 10.1038/nrm223610.1038/nrm2236 ↗
34. 10.1016/j.biomaterials.2016.12.01910.1016/j.biomaterials.2016.12.019 ↗
35. 10.1078/0171-9335-0034610.1078/0171-9335-00346 ↗
36. 10.1093/jnci/djm13510.1093/jnci/djm135 ↗
37. Netti P. A. · Cancer Res. · 2000 · 60 · 2497
38. 10.1016/j.nano.2015.11.02010.1016/j.nano.2015.11.020 ↗
39. Beola L. · 317
40. Kobayashi T. · 2016 · 137
41. 10.1021/nn204543c10.1021/nn204543c ↗
42. 10.1002/jcp.2016610.1002/jcp.20166 ↗
43. 10.1039/C7NJ01822C10.1039/C7NJ01822C ↗
44. 10.1021/acsami.7b1864810.1021/acsami.7b18648 ↗
45. 10.2217/nnm.15.7010.2217/nnm.15.70 ↗
46. 10.1016/j.actbio.2017.05.04710.1016/j.actbio.2017.05.047 ↗
47. 10.1021/nn405356r10.1021/nn405356r ↗
48. Privalov P. L. · 1982 · 35 · 1
49. 10.1016/j.tca.2011.10.02810.1016/j.tca.2011.10.028 ↗
50. 10.1016/S0959-8049(02)00210-110.1016/S0959-8049(02)00210-1 ↗
51. 10.1038/nrurol.2016.23810.1038/nrurol.2016.238 ↗
52. 10.1007/s00418-017-1604-210.1007/s00418-017-1604-2 ↗
53. 10.1097/00006676-200401000-0000610.1097/00006676-200401000-00006 ↗
54. 10.1007/978-1-60327-017-5_210.1007/978-1-60327-017-5_2 ↗
55. 10.1007/PL0000070710.1007/PL00000707 ↗
56. 10.1007/s12192-013-0463-610.1007/s12192-013-0463-6 ↗
57. 10.1242/jcs.0137410.1242/jcs.01374 ↗
58. 10.1007/s11095-012-0710-z10.1007/s11095-012-0710-z ↗
59. 10.2147/IJN.S13901110.2147/IJN.S139011 ↗
60. 10.1002/adfm.20180366010.1002/adfm.201803660 ↗
61. 10.1021/acs.jpcc.5b0255510.1021/acs.jpcc.5b02555 ↗
62. 10.1021/acsnano.7b0899510.1021/acsnano.7b08995 ↗
63. 10.1088/0031-9155/52/16/02210.1088/0031-9155/52/16/022 ↗
64. 10.1039/C3CP54763A10.1039/C3CP54763A ↗
65. 10.1021/ja038085210.1021/ja0380852 ↗
66. 10.1002/anie.20130583510.1002/anie.201305835 ↗